LAUREN P SILVERNAIL
CIK 1225755 · See Remarks · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$990.4K
Companies
7
Total Filings
70
Lifetime Open-Market Net
-$3.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HROW | Director | 1,000 | $37.64 | $37.6K | $31.0K | 1 | 2026-05-19 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Director | 0 | $15.50 | $0 | $0 | 3 | 2026-02-10 |
| HARROW, INC. (HROWM) Delisted | Director | — | $26.03 | — | $0 | 3 | 2025-06-24 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | Director | 0 | $23.01 | $0 | $0 | 4 | 2024-03-11 |
| EOLS | See Remarks | 141,571 | $6.73 | $952.8K | -$1.03M | 12 | 2022-05-18 |
| Revance Therapeutics, Inc. (RVNC) Delisted | CFO & CBO | 65,497 | $3.65 | $239.1K | -$2.31M | 25 | 2018-05-24 |
| ISTA PHARMACEUTICALS INC (ISTA) Delisted | Chief Financial Officer | 177,709 | — | — | $21.4K | 21 | 2012-05-10 |
Recent Filings · Page 5 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-23 | Revance Therapeutics, Inc. (RVNC) Delisted | Tax (F) | −1,753 | -$30.0K | EDGAR |
| 2016-02-04 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2016-02-01 | Revance Therapeutics, Inc. (RVNC) Delisted | Tax (F) | −1,063 | -$21.6K | EDGAR |
| 2016-01-04 | Revance Therapeutics, Inc. (RVNC) Delisted | Other (J) | +339 | $9.2K | EDGAR |
| 2015-07-02 | Revance Therapeutics, Inc. (RVNC) Delisted | Other (J) | +633 | $9.0K | EDGAR |
| 2015-05-21 | Revance Therapeutics, Inc. (RVNC) Delisted | Tax (F) | −1,753 | -$45.5K | EDGAR |
| 2015-01-30 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +7,290 | $0 | EDGAR |
| 2014-12-15 | Revance Therapeutics, Inc. (RVNC) Delisted | Buy (P) | +980 | $17.4K | EDGAR |
| 2012-06-15 | — | Disp (D) | −187,141 | -$1.70M | |
| 2012-05-10 | ISTA PHARMACEUTICALS INC (ISTA) Delisted | Mixed | +65,236 | $14 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.